Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 6 of the 32 sources its claims cite were checked for support.
Abstract
BACKGROUND: Worldwide, adults and children are at risk of adrenal insufficiency as a result of adrenal suppression from use of anti-inflammatory glucocorticoids and opiates, as well as infectious diseases. The adrenocorticotropin (ACTH) stimulation test is the reference standard for diagnosis of adrenal insufficiency but requires clinic attendance and venesection. Salivary cortisone reflects free serum cortisol, and samples can be collected at home and posted to a laboratory. We tested whether home waking salivary cortisone level could be used to screen for adrenal insufficiency. METHODS: A prospective, diagnostic accuracy study was performed in patients at high risk of adrenal insufficiency. Patients collected a home salivary sample on waking and then attended the clinical facility for an ACTH stimulation test. Salivary cortisone was measured by liquid chromatography–tandem mass spectrometry. Receiver-operating characteristic curves were computed, and positive and negative predictive values were calculated. RESULTS: Two hundred twenty patients were recruited. As measured by an ACTH stimulation test, the prevalence of adrenal insufficiency was 44%. The area under the receiver-operating characteristic curve for waking salivary cortisone as a predictor of adrenal insufficiency was 0.95 (95% confidence interval [CI], 0.92 to 0.97). Cutoffs to ensure a minimum of 95% sensitivity and specificity gave a negative predictive value of 96% (95% CI, 90 to 99) and a positive predictive value of 95% (95% CI, 87 to 99) to exclude and confirm adrenal insufficiency, respectively. Waking salivary cortisone data provided information similar to that of an ACTH stimulation test in 70% of participants. Eighty-three percent of patients preferred home salivary collection to clinic attendance. CONCLUSIONS: Home waking salivary cortisone sampling has accuracy for the diagnosis of adrenal insufficiency similar to that of a standard ACTH stimulation test. Patients found the at-home test to be more convenient than the hospital-based test. (Funded by the National Institute for Health Research.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 14 Not checked · 71 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“diagnosis is often delayed [10][11][12][13]”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Introduction A
What the sources say
- Not checked yetcites [10] matched to “Predisposing Factors for Adrenal Insufficiency” (2009) source
- Partly supportedcites [11] matched to “Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: a Danish population-based self-controlled case series analysis” (2019) sourceExperimental — accuracy not yet measured
The closest statement in our copy is in the Discussion (limitations paragraph): only 49 persons had a recorded diagnosis of treatment-induced adrenal insufficiency, and 'this small number most likely reflects lack of awareness and failure to diagnose iatrogenic adrenal insufficiency' — echoed in the Results ('Only 49 persons were coded with treatment-induced adrenal insufficiency during the observation period'). That supports under-recognition/non-diagnosis of glucocorticoid-induced (iatrogenic/tertiary) adrenal insufficiency in a Danish nationwide registry cohort, and it is hedged ('most likely reflects'). It does not state that diagnosis is 'often delayed' (a timing claim), nor does it address adrenal insufficiency in general or primary/secondary disease, which the citing sentence's unqualified wording carries. The Introduction's related framing is only that clinical implications rest on 'anecdotal reports' and that guidelines lack evidence-based recommendations [20, 21]. (LLM, conf=0.68)
- Not checked yetcites [12] matched to “High Incidence of Adrenal Crisis in Educated Patients With Chronic Adrenal Insufficiency: A Prospective Study” (2015) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“approximately 10% of patients taking opioids at a morphineequivalent dose of >20 mg/d are at risk of adrenal insufficiency.5”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Introduction A
What the sources say
- Supportedcites [5] matched to “Prevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids” (2020) source
The Discussion reports a 9% prevalence of opioid-induced adrenal insufficiency among patients taking chronic opioids for noncancer pain. The Adrenal function section says no patient taking less than 20 mg/day in morphine milligram equivalents developed it, and the Discussion recommends evaluation above 20 mg/day. Together, these support the approximate one-in-ten risk statement in the study’s chronic-pain context. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The standard test for adrenal insufficiency is the adrenocorticotropin (ACTH) stimulation test, also called the short Synacthen test.13,15,16”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Introduction A
What the sources say
- Supportedcites [13] matched to “Diagnosis and management of adrenal insufficiency” (2015) source
The Diagnosis of Adrenal Insufficiency section (p. 8) identifies the ACTH stimulation test as the short Synacthen test and says it is commonly used to diagnose adrenal insufficiency. The same section says an ACTH stimulation test should be performed to establish the diagnosis safely, supporting its description as the standard test. (LLM, conf=0.93)
- Not checked yetcites [15] matched to “The short Synacthen test: a questionnaire survey of current usage” (2012) source
- Not checked yetcites [16] matched to “ACTH stimulation tests for the diagnosis of adrenal insufficiency: systematic review and meta-analysis” (2016) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Salivary cortisol is derived from serum-free cortisol, and late-night salivary cortisol is used in the diagnosis of Cushing's syndrome.22,23”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Introduction A
What the sources say
- Supportedcites [22] matched to “The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.” (2008) source
Section 3.4.2 'Evidence for late-night salivary cortisol' states that 'Biologically active free cortisol in the blood is in equilibrium with cortisol in the saliva,' which supports the claim that salivary cortisol derives from serum-free cortisol. The same section, together with 3.4.2 Remarks, presents late-night salivary cortisol as a screening/diagnostic test for Cushing's syndrome (reference ranges at 2300-2400 h, loss of nadir in CS), so the second half of the sentence is also covered by this guideline. (LLM, conf=0.90)
- Not checked yetcites [23] matched to “Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome” (2008) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A waking salivary cortisol cutoff value of 180 ng/dl (5 nmol/l) excluded adrenal insufficiency with a sensitivity of 95% (95% CI, 88 to 99) and an NPV of 94% (95% CI, 85 to 98);”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > SECONDARY MEASURES
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
36 more claims
Create a free account to see all 91 claims and to verify the 26 references still open.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 31
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A baseline serum cortisol < 152 nmol/L (< 5.5 μg/dL) confirmed glucocorticoid-induced adrenal insufficiency with a specificity of 97% and a positive predictive value of 95%.”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [55]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Debono et al found that a baseline serum cortisol >310 nmol/L (>11.2 μg/dL) measured by immunoassay excluded glucocorticoid-induced adrenal insufficiency with a sensitivity of 98% and a negative predictive value of 97% (data retrieved after contacting the authors) (55).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [55]
Experimental — accuracy not yet measuredIn the citing paper
“Morning salivary cortisol and cortisone are not expected to contribute significantly to CS diagnosis, but may be useful for screening of adrenal insufficiency [45].”
From Salivary cortisol and cortisone in diagnosis of Cushing's syndrome: a comparison of six different analytical methods (2023) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Discussion
“Data from this test would have been sufficient to allow the provider to make an accurate diagnosis in 70% of individuals at risk of adrenal insufficiency.”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > SECONDARY MEASURES
“The ACTH stimulation test would have been avoided in 70% (154 of 220) of participants -73 patients with waking salivary cortisone <251 ng/dl (7 nmol/l) and 81 patients with waking salivary cortisone 612 ng/dl (17 nmol/l).This two-stage process resulted in four patients who were falsely positive and three patients who were falsely negative (Table S2 and Table S3).”
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Self-citationBornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Diagnosis and management of adrenal insufficiency
Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70142-1 · Cited by 467
Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis
Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1218 · Cited by 456
Erichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422
Prevalence of oral glucocorticoid usage in the United States: a general population perspective
Overman, R. A., Yeh, J., & Deal, C. L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21796 · Cited by 405
Hahner, S., Spinnler, C., Fassnacht, M., Burger-Stritt, S., Lang, K., Milovanovic, D., Beuschlein, F., Willenberg, H. S., Quinkler, M., & Allolio, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3191 · Cited by 394
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis
Kazlauskaite, R., Evans, A. T., Villabona, C. V., Abdu, T. A. M., Ambrosi, B., Atkinson, A. B., Choi, C. H., Clayton, R. N., Courtney, C. H., Gonc, E. N., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0710 · Cited by 385
Diagnosis of Adrenal Insufficiency
Dorin, R. I., Qualls, C. R., & Crapo, L. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00009 · Cited by 374
Cited by
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae250 · Cited by 172
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L. T., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae029 · Cited by 156
Adrenal Insufficiency in Adults: A Review
Vaidya, A., Findling, J., & Bancos, I. (2025) · JAMA · doi:10.1001/jama.2025.5485 · Cited by 75
Diagnosis and management of adrenal insufficiency
Lewis, A., Thant, A. A., Aslam, A., Aung, P. P. M., & Azmi, S. (2023) · Clinical Medicine · doi:10.7861/clinmed.2023-0067 · Cited by 68
Iatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
“%) and <7 nmol/l predicted short synacthen test failure (specificity 97%), reducing the need for a short synacthen test by 70% 242,243 and was a superior predictor of short synacthen test results than morning serum cortisol levels.”
Metadata
- Authors
- Debono, M., Elder, C. J., Lewis, J., Fearnside, J., Caunt, S., Dixon, S., Jacques, R. M., Newell-Price, J., Whitaker, M. J., Keevil, B., & Ross, R. J.
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Sheffield (GB)
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Ross, Richard J.
- ORCID
- Venue
- NEJM Evidence
- Publisher
- Massachusetts Medical Society
- Published
- 2023-01-24
- Volume
- 2
- Issue
- 2
- Pages
- EVIDoa2200182-EVIDoa2200182
- ISSN
- 2766-5526 (ISSN-L)
- OpenAlex
- W4313650042
- Semantic Scholar
- 41e470bb5f396fb14a33abbc635c0ffef42d8d13
- Cited by
- 66
- References
- 32
- Citations by year
- 2026: 8 · 2025: 25 · 2024: 21 · 2023: 12
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- Locations
- NEJM Evidence (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Funders
- National Institute for Health and Care Research (PB-PG-1217-20007, CL-2015-04-002)
- Academy of Medical Sciences (SGL015\1007)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- adrenal insufficiency, salivary cortisone, home sampling, ACTH stimulation test, diagnostic accuracy, free cortisol, glucocorticoid-induced adrenal suppression, patient preferences
- MeSH terms
- Adrenal Insufficiency, Cortisone, Humans, Hydrocortisone, Prospective Studies, Saliva
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency. https://app.cochat.ai/papers/10.1056/evidoa2200182
- The paper
- Debono, M., Elder, C. J., Lewis, J., Fearnside, J., Caunt, S., Dixon, S., Jacques, R. M., Newell-Price, J., Whitaker, M. J., Keevil, B., & Ross, R. J. (2023). Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency. NEJM Evidence. https://doi.org/10.1056/evidoa2200182
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.